Mezon Pharmaceuticals Private Limited
About Mezon Pharmaceuticals Private Limited
Data last updated:
Mezon Pharmaceuticals Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the pharmaceutical distribution segment of the pharmaceuticals sector. It was incorporated on 15 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2010PTC034274. Its GSTIN is 03AAGCM8591D1ZG (Punjab).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Rajesh Dutt (Managing Director) and Ankit Dutt.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pink Flat No. 63 Sant Isher Singh Nagar Pakhowal, Ludhiana, Punjab, India – 141002.
As per the financials filed for FY 2024, the company reported a revenue of ₹62.12 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹4.07 Lakh (net margin -6.5%) and EBITDA of -₹1.22 Lakh (EBITDA margin -2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.5 Lakh and satisfied charges of ₹50 Lakh on record. Court records list 1 case involving the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPink Flat No. 63 Sant Isher Singh Nagar Pakhowal, Ludhiana, Punjab, India – 141002
- IndustryPharmaceuticals, Pharmaceutical Distribution, Distributors, Retailors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mezon Pharmaceuticals Private Limited
The main business activity of Mezon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mezon Pharmaceuticals Private Limited FY 2025 filings available
Mezon Pharmaceuticals Private Limited reported revenue of ₹62.12 Lakh (down 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mezon Pharmaceuticals Private Limited
Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 134% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mezon Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.22 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.07 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mezon Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mezon Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals Private Limited is audited by J. Bansal & Associates for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J. Bansal & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Dutt | Managing Director | 15 Sep 2010 | 16 Years 0 Months | Current |
| Ankit Dutt | Director | 01 Jan 2020 | 6 Years 9 Months | Current |
Ownership and Shareholding of Mezon Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mezon Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2022 | Hdfc Bank Limited | ₹12.5 Lakh | Open |
| 09 Aug 2012 | Bank of India | ₹50 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals Private Limited has 1 court case on record: 1 where it is another party. All case is pending. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Bilaspur, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Company is another party | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals Private Limited has a workforce of 6 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Ankit Dutt was appointed as Director on 01 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Mezon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mezon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mezon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAGCM8591D1ZG | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mezon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mezon Pharmaceuticals Private Limited
Mezon Pharmaceuticals is an active private limited company based in Ludhiana, Punjab, India. The company works in pharmaceutical distribution, within the pharmaceuticals industry. It was incorporated on 15 September 2010 (16+ years old) and is registered under CIN U24232PB2010PTC034274.
Mezon Pharmaceuticals reported revenue of ₹62.12 Lakh for FY 2024 (down 16% YoY).
Mezon Pharmaceuticals has 2 current directors:
- Rajesh Dutt - Managing Director
- Ankit Dutt - Director
Mezon Pharmaceuticals reported a net loss of ₹4.07 Lakh (net margin -6.5%) and EBITDA of -₹1.22 Lakh (EBITDA margin -2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mezon Pharmaceuticals is 2% over three years and 6% over five years. In the latest year (FY 2024) revenue fell 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mezon Pharmaceuticals is 03AAGCM8591D1ZG, registered in Punjab.
The CIN (Corporate Identification Number) of Mezon Pharmaceuticals is U24232PB2010PTC034274. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mezon Pharmaceuticals has 1 court case on record. 1 is pending.
Mezon Pharmaceuticals was incorporated on 15 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chandigarh.
Ankit Dutt was appointed as Director on 01 Jan 2020. Savita Dutt ceased to be Director on 01 Jan 2020. Rajesh Dutt was appointed as Managing Director on 15 Sep 2010. Mezon Pharmaceuticals has 4 board changes on record in total.